About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in New York | 76 Studies

Clinical Trials Alzheimer's DiseaseNew York

Alzheimer's Disease Clinical Trials in New York

Find 76 clinical trials for alzheimer's disease near New York, New York. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in New York

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 76 trials

CompletedMemantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health OutcomeThis study is a retrospective review of the data collected in a previously completed randomized, controlled trial (RCT) entitled "Memantine and Comprehensive, Individualized…NCT02854917·New York, New York CompletedMulticenter Trial of Prednisone in Alzheimer's DiseaseThis is a randomized placebo controlled, double blind study.NCT00000178·Birmingham, Alabama and 18 others

Alzheimer's Disease Trials in Other Cities

Los Angeles Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedDHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's DiseaseThe purpose of this study is to determine whether chronic DHA (Docosahexaenoic Acid) supplementation slows the progression of cognitive and functional decline in mild to moderate…NCT00440050·Birmingham, Alabama and 50 others

TerminatedProgress of Mild Alzheimer's Disease in Participants on Solanezumab Versus PlaceboTo test the idea that solanezumab will slow the cognitive decline of Alzheimer's Disease (AD) as compared with placebo in participants with mild AD.NCT01900665·Phoenix, Arizona and 197 others

CompletedAnti-viral Therapy in Alzheimer's DiseaseAnti-viral therapy in Alzheimer's disease will investigate the efficacy of treating patients with mild Alzheimer's disease with the U.S.A marketed generic anti-viral drug Valtrex…NCT03282916·Phoenix, Arizona and 2 others

Terminated221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's DiseaseThe primary objective of the study is to evaluate the efficacy of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical…NCT02484547·Birmingham, Alabama and 179 others

CompletedMemantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive ImpairmentAlzheimer's disease (AD), the most common dementing disorder of later life, is a major cause of disability and death in the elderly.NCT01876823·New York, New York

CompletedA Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)The primary specific aim of this clinical trial is to determine whether treatment with rofecoxib or naproxen for one year will slow the rate of decline of cognitive function in…NCT00004845·Phoenix, Arizona and 39 others

WithdrawnBrain Sleep Deprivation MRI Effects (BEDTIME)The primary purpose of this study is to explore the underlying mechanisms that link sleep to Alzheimer's disease (AD), with special focus on the clearance of metabolites in the…NCT02741505·New York, New York

CompletedHome-Based Assessment for Alzheimer Disease PreventionThe purpose of this study is to evaluate three methods of performing home-based assessments in Alzheimer's Disease (AD) prevention trials.NCT00546767·Birmingham, Alabama and 27 others

CompletedPhosphoRus, Proton Imaging and Amyloid BuRdEn (PREPARE) ON AMYLOID BURDEN AND COGNITIONNormal cells primarily produce energy with the help of the "mitochondria".NCT03999879·New York, New York

Active not recruitingA Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's DiseaseThis study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiority of lecanemab compared with…NCT03887455·Phoenix, Arizona and 246 others

TerminatedStudy Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease PatientsThis is a study to evaluate the efficacy and safety of multiple doses of bapineuzumab in patients with mild to moderate Alzheimer Disease.NCT00676143·Birmingham, Alabama and 287 others

TerminatedBiological Sample Collection for Research and BiobankingThe New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to study different conditions and diseases by using cells from the body (such as skin or…NCT04270604·New York, New York

RecruitingThe Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults StudyThe Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL) study is a 5-year, multicenter randomized open-label trial that will screen 400…NCT05988385·Tucson, Arizona and 3 others

CompletedOrexin and Tau Pathology in Cognitively Normal ElderlyAlzheimer's disease (AD) is a common neurodegenerative disease characterized by the accumulation of amyloid plaques and neurofibrillary tangles.NCT03053908·New York, New York

Terminated221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's DiseaseThe primary objective of the study is to evaluate the efficacy of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical…NCT02477800·Phoenix, Arizona and 180 others

TerminatedVideofluoroscopic Swallowing Study (VFSS)The study procedure of simultaneous VFSS and DDS measurement will be completed in one day and the subject will be followed within 2 business days after the study procedure to…NCT03387267·Downey, California and 12 others

TerminatedPhase 2 Study of BIIB092 in Participants With Early Alzheimer's DiseaseThe primary objective of the placebo-controlled period is to evaluate the safety and tolerability of BIIB092 in participants with mild cognitive impairment (MCI) due to…NCT03352557·Birmingham, Alabama and 100 others

CompletedHealthy Aging and Memory StudyThis project will focus on the development and testing of efficient, cost effective measures that are specifically designed for use in Alzheimer's Disease (AD) primary prevention…NCT00034567·Birmingham, Alabama and 38 others

Page 1 of 4Next

Other Conditions in New York

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia